特应性皮炎患者眼表疾病的实用管理,聚焦结膜炎:一篇综述
特应性皮炎(AD)常伴眼表疾病(OSD),结膜炎是最常见的OSD,且靶向2型炎症通路的单克隆抗体生物制剂可能增加其发生率。本综述旨在提高皮肤科医生对AD患者合并OSD的认识,聚焦结膜炎,并提供筛查、诊断、推荐治疗选择及转诊眼科专家的建议。
要点
- AD患者常合并眼表疾病,结膜炎是最常见的类型。
- 靶向2型炎症通路的生物制剂可能增加结膜炎发生率。
- 皮肤科医生应了解筛查、诊断、治疗及转诊眼科专家的时机。
核心结论
- 本综述旨在提高皮肤科医生对AD患者合并OSD的认识,聚焦结膜炎,并使皮肤科医生能够处理轻微眼部问题。
- 多学科协作旨在支持AD患者的整体健康并提供最佳患者照护。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- AD是一种慢性炎症性皮肤病,可显著降低生活质量。
- AD常合并症包括眼表疾病(OSD)。
- 结膜炎是与AD相关的最常见OSD,且使用靶向2型炎症通路的单克隆抗体生物制剂时发生率可能增加。
关键数值与推荐
- 原文未报告具体标准与数值。
临床怎么用
- 综述提供了皮肤科医生对AD患者合并OSD的筛查和诊断方法、推荐治疗选择以及转诊眼科专家的时机。
- 原文未据结论给出具体推荐等级。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atopic dermatitis (AD) is a chronic inflammatory skin disease that can significantly decrease quality of life. AD is commonly associated with comorbidities including ocular surface disease (OSD). Conjunctivitis is the most common OSD associated with AD and can increase in incidence with use of monoclonal antibody biologics that target the type 2 inflammatory pathway. The objective of this review is to raise awareness of comorbid OSD in AD patients that dermatologists may encounter, with a focus on conjunctivitis, and equip dermatologists to address mild ocular concerns. We provide background on the subtypes and pathogenesis of comorbid OSD in AD patients and describe OSD associated with type 2 inflammation-inhibiting AD biologics. We also discuss screening and diagnosis, recommended treatment options for dermatologists, and when to refer to an eye care specialist. This multispecialty approach aims to support the overall health of AD patients and provide optimal patient care.
引用
- Shi VY, Chamberlain W, Siegfried E, et al. Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review. J Am Acad Dermatol. 2023. PMID: 36806642. doi:10.1016/j.jaad.2023.01.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。